Whalesbook Logo

Whalesbook

  • Home
  • About Us
  • Contact Us
  • News

Analysts Maintain Positive Outlook on Bharti Airtel, Titan, Ambuja Cements, Ajanta Pharma; Westlife Foodworld Faces Headwinds

Brokerage Reports

|

Updated on 06 Nov 2025, 03:39 am

Whalesbook Logo

Reviewed By

Aditi Singh | Whalesbook News Team

Short Description:

Major financial analysts have issued buy ratings and target prices for Bharti Airtel, Titan Company, Ambuja Cements, and Ajanta Pharma, citing strong quarterly results and positive outlooks. Bharti Airtel reported steady Q2FY26 performance across segments, while Titan saw robust sales, particularly in jewellery and watches. Ambuja Cements met revenue expectations and increased its capacity target. Ajanta Pharma's Q2 results surpassed estimates with a strong outlook, especially in the US and Africa. However, Westlife Foodworld's Q2 EBITDA fell short of expectations, prompting concerns about industry recovery.
Analysts Maintain Positive Outlook on Bharti Airtel, Titan, Ambuja Cements, Ajanta Pharma; Westlife Foodworld Faces Headwinds

▶

Stocks Mentioned:

Bharti Airtel Limited
Titan Company Limited

Detailed Coverage:

Analysts are closely watching the performance of several Indian companies following their July-September quarter (Q2FY26) results. Citigroup reiterated a 'buy' rating on Bharti Airtel with a target price of Rs 2,225, highlighting steady growth in India mobile, homes, and business segments, with improved Average Revenue Per User (ARPU) offsetting slightly lower subscriber additions. Homes segment revenue and EBITDA grew by approximately 8.5%, exceeding estimates.

Nomura maintained a 'buy' rating on Titan Company, setting a target price of Rs 4,275. Despite slightly lower year-on-year margins, strong festive demand is expected to boost future performance. Jewellery sales were in line, while watches and eyecare showed growth, and emerging businesses reported a 34% year-on-year sales increase.

Morgan Stanley rated Ambuja Cements 'overweight' with a target price of Rs 650. The company's revenues were in line, with EBITDA per ton exceeding brokerage estimates. Ambuja Cements also raised its FY28 capacity target from 140 million tons to 155 million tons, driven by debottlenecking.

Macquarie maintained an 'outperform' rating on Westlife Foodworld with a target price of Rs 750. However, Q2FY26 EBITDA was below estimates, and concerns remain about limited signs of industry recovery despite company investments in growth.

Jefferies upgraded Ajanta Pharma's stock, reiterating a 'buy' rating with an increased target price of Rs 3,320. The company's September quarter numbers beat estimates, with strong outlooks for the USA and Africa. Analysts project an EBITDA margin of 27% due to ongoing investments.

Impact: These analyst ratings and performance updates can significantly influence investor sentiment and stock prices for the mentioned companies, potentially driving short-term trading activity and affecting broader sector performance. Analyst upgrades and positive earnings often lead to increased buying pressure, while missed expectations can trigger sell-offs. Impact Rating: 7/10

Difficult Terms: EBITDA: Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a profitability metric. ARPU: Average Revenue Per User. It measures the average revenue generated from each mobile subscriber. QoQ: Quarter-over-Quarter. A comparison of financial results from one quarter to the next. YoY: Year-over-Year. A comparison of financial results from a given period to the same period in the previous year. Debottlenecking: A process to increase the capacity or efficiency of a system by removing limiting factors or bottlenecks.


Mutual Funds Sector

When to Consider Pausing Your SIP Investments: Key Scenarios for Financial Health

When to Consider Pausing Your SIP Investments: Key Scenarios for Financial Health

HDFC Mid Cap Fund Delivers Stellar Returns, Outshines Peers

HDFC Mid Cap Fund Delivers Stellar Returns, Outshines Peers

Bandhan AMC Launches New Healthcare Fund to Tap India's Growth

Bandhan AMC Launches New Healthcare Fund to Tap India's Growth

Helios Flexicap Fund Shows Strong Returns with Unique Investment Strategy

Helios Flexicap Fund Shows Strong Returns with Unique Investment Strategy

When to Consider Pausing Your SIP Investments: Key Scenarios for Financial Health

When to Consider Pausing Your SIP Investments: Key Scenarios for Financial Health

HDFC Mid Cap Fund Delivers Stellar Returns, Outshines Peers

HDFC Mid Cap Fund Delivers Stellar Returns, Outshines Peers

Bandhan AMC Launches New Healthcare Fund to Tap India's Growth

Bandhan AMC Launches New Healthcare Fund to Tap India's Growth

Helios Flexicap Fund Shows Strong Returns with Unique Investment Strategy

Helios Flexicap Fund Shows Strong Returns with Unique Investment Strategy


Commodities Sector

SEBI Cautions Investors Against Unregulated Digital Gold Products

SEBI Cautions Investors Against Unregulated Digital Gold Products

Gold and Silver Prices Decline for Third Consecutive Week Amidst Stronger Dollar and Fed Caution

Gold and Silver Prices Decline for Third Consecutive Week Amidst Stronger Dollar and Fed Caution

India Notifies New Deep-Sea Fishing Rules, Prioritizing Indian Fishers and Banning Foreign Vessels

India Notifies New Deep-Sea Fishing Rules, Prioritizing Indian Fishers and Banning Foreign Vessels

SEBI Cautions Investors Against Unregulated Digital Gold Products

SEBI Cautions Investors Against Unregulated Digital Gold Products

Gold and Silver Prices Decline for Third Consecutive Week Amidst Stronger Dollar and Fed Caution

Gold and Silver Prices Decline for Third Consecutive Week Amidst Stronger Dollar and Fed Caution

India Notifies New Deep-Sea Fishing Rules, Prioritizing Indian Fishers and Banning Foreign Vessels

India Notifies New Deep-Sea Fishing Rules, Prioritizing Indian Fishers and Banning Foreign Vessels